Jonathan Block is a Managing Editor at Seeking Alpha. He specializes in finance and healthcare, with a focus on topics such as pharmaceutical regulation, mental health, and consumer health. His insights and analyses have been featured in The National Law Review, NewsBreak, Defiance Crescent News, JD Supra, and Seeking Alpha.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
United States (National)
Not enough data
Jonathan Block's coverage focuses on investment analysis, press releases, and data citations related to sales & marketing and automotive industries. He would likely be interested in pitches that provide in-depth analysis of stock performance, company news, and market trends within these sectors.
Given his focus on investment analysis and citation of data, Jonathan may find value in pitches from financial experts who can offer unique insights into the potential impact of various factors on stock performance or industry trends.
While Jonathan does not have a specific geographic focus mentioned but given the nature of his articles focusing mainly on companies listed in US stock exchanges (NASDAQ: HAS; NYSE: MTN), it is safe to assume he has an interest primarily in the US market.
This information evolves through artificial intelligence and human feedback. Improve this profile .
rabbit75_ist MiMedx ( MDXG ) is up ~4% in Thursday trading after Craig-Hallum raised its price target to $8 from $6 (~81% upside based on
Brandon Bell/Getty Images News James Talarico, the Texas Democrat running for US Senate, is partnering with Mark Cuban to launch a healthcare
Jeff Colburn/iStock Editorial via Getty Images The US FDA has approved Moderna's ( MRNA Spikevax and mNEXSPIKE COVID-19 vaccines for the 2026-27 season.
carmengabriela Pfizer ( PFE ) and BioNTech's ( BNTX ) mRNA COVID-19 vaccine, COMIRNATY XFG, was approved by the US FDA for the 2026-27 season.
Regenxbio ( RGNX ) is up ~3% in Friday morning trading after recently appointed director Gregory Austin Ciongoli bought more than 102,000 shares valued at more than $949,000.
Tim Boyle/Getty Images News Walmart ( WMT ) has reached a settlement with the Justice Department over a lawsuit that accused the retailer's pharmacies of ignoring red flags associated with many opioid prescriptions.
By: Jonathan Block
BioNTech ( BNTX ) is down ~8% in Friday trading after reporting that it is abandoning a phase 2 trial of its mRNA immunotherapy autogene cevumeran for colorectal cancer due to efficacy concerns.
tylim/iStock via Getty Images The US FDA has expanded the use of Johnson & Johnson's ( JNJ ) Stelara (ustekinumab) to pediatric patients two years and older with moderately to severely active ulcerative colitis.
By: Jonathan Block
FDA expands Johnson & Johnson’s Stelara for pediatric ulcerative colitis (ages 2+), backed by clinical data and orphan drug status. Read more here.
Dr_Microbe/iStock via Getty Images The US FDA approved Takeda Pharmaceutical's ( TAK Mimrylo (rusfertide), a first-in-class treatment for the rare blood disorder polycythemia vera.
